AT-RISK: AuToimmune disorders and cardiovascular RISK

AT-RISK: AuToimmune disorders and cardiovascular RISK

Bibliographic Details
Main Authors:	Conrad, N, Verbeke, G, Molenberghs, G, Goetschalckx, L, Callender, T, Rahimi, K, Mason, JC, McMurray, JJV, Verbakel, JY
Format:	Conference item
Language:	English
Published:	Oxford University Press 2022

Similar Items

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
by: Conrad, N, et al.
Published: (2022)

Cardiovascular risk in systemic autoimmune diseases – authors' reply
by: Conrad, N, et al.
Published: (2023)

Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
by: Conrad, N, et al.
Published: (2023)

Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls
by: Ferguson, LD, et al.
Published: (2024)

Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?
by: Conrad, N, et al.
Published: (2022)

Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study
by: Conrad, N, et al.
Published: (2024)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
by: Wamil, M, et al.
Published: (2021)

Autoimmune diseases and cardiovascular risk: Mendelian randomization analysis for the impact of 19 autoimmune diseases on 14 cardiovascular conditions
by: Yulin Bao, et al.
Published: (2024-12-01)

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
by: Kristensen, SL, et al.
Published: (2019)

Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
by: Daniel J. DeMizio, et al.
Published: (2019-12-01)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
by: Wamil, M, et al.
Published: (2020)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
by: Bethel, M, et al.
Published: (2013)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
by: Bethel, M, et al.
Published: (2013)

Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86,000 individuals
by: Conrad, N, et al.
Published: (2019)

Risk prediction in patients with heart failure: a systematic review and analysis.
by: Rahimi, K, et al.
Published: (2014)

Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
by: Chary López-Pedrera, et al.
Published: (2012-01-01)

Cardiovascular risk and inflammation in a population with autoimmune diseases: a narrative review
by: Camilla Bertoni, et al.
Published: (2024-03-01)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
by: Dos Santos, M, et al.
Published: (2017)

The year in cardiology: heart failure. The year in cardiology 2019
by: J.G.F. Cleland, et al.
Published: (2020-04-01)

Prediabetes and the risk of diabetes.
by: McMurray, J, et al.
Published: (2012)

Risk prediction in patients with heart failure: a systematic review and analysis
by: Bennett, D, et al.
Published: (2014)

Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial.
by: de Barros e Silva, P, et al.
Published: (2014)

Models for discrete longitudinal data /
by: 381799 Molenberghs, Geert, et al.
Published: (2005)

High risk surveillance outcomes in women with breast cancer gene mutations.
by: R. McMurray, et al.
Published: (2024-04-01)

Overexpression of the Cytokine BAFF and Autoimmunity Risk.
by: Steri, M, et al.
Published: (2017)

The Relationship between TSH Values and Cardiovascular Risk Factors in Patients with Autoimmune Thyroiditis and Subclinical Hypothyroidism
Published: (2014-06-01)

Autoimmunity and the risk of myeloproliferative neoplasms
by: Sigurdur Y. Kristinsson, et al.
Published: (2010-07-01)

Pregnancy and the risk of autoimmune disease.
by: Ali S Khashan, et al.
Published: (2011-01-01)

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
by: Marilia Harumi Higuchi dos Santos, et al.
Published: (2017-01-01)

16 Management of cardiovascular risk in SLE
by: Murray Urowitz, et al.
Published: (2020-09-01)

Calcium evaluation in coronary arteries: new possibilities of cardiovascular complications risk stratification in patients with autoimmune diseases
by: D S Novikova, et al.
Published: (2009-06-01)

Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future
by: Anna Mandel, et al.
Published: (2022-06-01)

Peripartum Antibiotics Exposure and the Risk of Autoimmune and Autism Disorders in the Offspring
by: Jehad Almasri, et al.
Published: (2021-08-01)

Improving cardiovascular risk stratification through multivariate time-series analysis of cardiopulmonary exercise test data
by: Evangelos Ntalianis, et al.
Published: (2024-09-01)

Editorial: Autoimmunity and cardiovascular diseases
by: Shahad Saif Khandker, et al.
Published: (2023-07-01)

CARDIOVASCULAR MANIFESTATIONS IN AUTOIMMUNE DISEASES
by: Alina-Costina LUCA, et al.
Published: (2016-06-01)

Survival and autoimmune risks post-thymectomy
by: Irina Tsirkin, et al.
Published: (2025-03-01)

Autoimmunity and risk for Hodgkin’s lymphoma by subtype
by: Sigurdur Y. Kristinsson, et al.
Published: (2009-10-01)

Cardiovascular Risk in Individuals with Inflammatory Bowel Disease
by: Biondi RB, et al.
Published: (2020-04-01)

Blood pressure and risk of vascular dementia: evidence from a primary care registry and a cohort study of transient ischemic attack and stroke
by: Emdin, C, et al.
Published: (2016)